Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -3.54EBITDA per Share
VS
Market
Sector
Industry
History
$ 1.23Close
$ 0.68 - $ 12.05 52-Week Range
Ticker Information
Ticker
CTXRCompany Name
CITIUS PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCITIUS PHARMACEUTICALS INC - EBITDA per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CTXR - EBITDAPS Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -38.95M | $ -3.54 | 1 | 11.01M |
| 3/31/2025 | $ -41.01M | $ -4.78 | 1 | 8.58M |
| 12/31/2024 | $ -38.77M | $ -5.17 | 1 | 7.49M |
| 9/30/2024 | $ -38.35M | $ -5.7 | 1 | 6.73M |
| 6/30/2024 | $ -37.51M | $ -5.39 | 1 | 6.95M |
| 3/31/2024 | $ -35.42M | $ -5.57 | 1 | 6.36M |
| 12/31/2023 | $ -37.41M | $ -5.88 | 1 | 6.36M |
| 9/30/2023 | $ -31.77M | $ -5.25 | 1 | 6.05M |
| 6/30/2023 | $ -29.39M | $ -4.78 | 1 | 6.15M |
| 3/31/2023 | $ -29.92M | $ -5.11 | 1 | 5.85M |
Key Performance Insights, Last 5 Years
- CITIUS PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -11.09.
- Over the past 5 years, CITIUS PHARMACEUTICALS INC's average EBITDAPS has been $ -5.54.
- The median EBITDAPS for CITIUS PHARMACEUTICALS INC during this period was $ -5.23
- CITIUS PHARMACEUTICALS INC reached its highest EBITDAPS over the past 5 years at $ -3.54.
- The lowest EBITDAPS recorded by CITIUS PHARMACEUTICALS INC in the same timeframe $ -11.09
Similar metrics to Shares WA:
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBITDA per Share
[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for CITIUS PHARMACEUTICALS INC is calculated as follows: EBITDA [ $ -17.38M ] / (Shares WA [ 1.57M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -11.09 ] CTXR - EBITDA per Share, Last 5 years
$ -11.09
Minimum
Sep 30, 2020
$ -3.54
Maximum
Jun 30, 2025
$ -5.54
Average
$ -5.23
Median
EBITDAPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
| filtered constituents | 3.78K |
|---|---|
| min | $ -11.29 |
| max | $ 14.03 |
| average | $ 2.03 |
| median | $ 1 |
| std | $ 4.28 |